Company
Every investor coverage indicates participated in a round BioScience Managers raised.
Companies BioScience Managers acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming BioScience Managers. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Percheron Therapeutics has appointed Arovella Therapeutics' former leader Michael Baker as CEO from October, with James Garner departing for an overseas role while joining the board as a non-executive director.
Global Kinetics, a Melbourne-based digital neurology company, names Zach Henderson its chief executive; Leighton Read shifts to non-executive chair and BioScience Managers' David Atkins joins the board.
Global Kinetics, a Melbourne-based digital health company focused on neurology, has appointed industry veteran Zach Henderson, formerly of Glooko, as chief executive, while also adding BioScience Managers' David Atkins to its board.
Weekly roundup reporting seven startup raises, led by Fluent Commerce's Series B backed by Arrowroot Capital, plus funding for SpeeDx, eftsure, handdii, Pharmamark Nutrition, DC Power Co and Lumary.
The industry minister announced Biomedical Translation Fund backing: Brandon Capital invested $20 million in Respirion, OneVentures $4 million in Madorra, and $17.2 million went to an unnamed anti-fibrosis drug company.